1. Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial. Issue 6 (June 2021) Authors: Fennell, Dean A; King, Amy; Mohammed, Seid; Branson, Amy; Brookes, Cassandra; Darlison, Liz; Dawson, Alan G; Gaba, Aarti; Hutka, Margaret; Morgan, Bruno; Nicholson, Adrian; Richards, Cathy; Wells-Jordan, Peter; Murphy, Gavin James; Thomas, Anne; Fennell, Dean Anthony; King, Amy; Mohammed, Seid; B... Journal: Lancet Issue: Volume 9:Issue 6(2021) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗